Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text

Medicine, Oncology, Pharmacology +14

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 3.6K citations

Medicine, Oncology, Chemotherapy +10

British National Formulary

Journal of the American Pharmaceutical Association (Scientific ed ) · 1958 · 2.5K citations

Modelling for Survival Data in Medical Research

Technometrics · 1995 · 2.2K citations

Public Health, Biostatistics, Epidemiologic Methods +13

Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma

Robert J. Motzer, Madhu Mazumdar, Jennifer Bacik et al. · Journal of Clinical Oncology · 1999 · 1.8K citations

Medicine, Biostatistics, Oncology +17